Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2015

Dec 21, 2015

30643_dirs_2015-12-21_24d11a02-61d9-425c-9316-8d03e4a7fa53.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2015-12-17

Reporting Person: Mildenberger Laura (Chief People Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-17 Common Stock M 7300 $43.35 Acquired 14110 Direct
2015-12-17 Common Stock F 4645 $68.13 Disposed 9465 Direct
2015-12-17 Common Stock S 1242 $68.1333 Disposed 8223 Direct
2015-12-17 Common Stock M 2250 $55.34 Acquired 10473 Direct
2015-12-17 Common Stock F 1828 $68.13 Disposed 8645 Direct
2015-12-17 Common Stock S 198 $68.15 Disposed 8447 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-12-17 Stock Appreciation Rights $43.35 M 7300 Disposed 2016-04-13 Common Stock (7300) Direct
2015-12-17 Stock Appreciation Rights $55.34 M 2250 Disposed 2017-12-18 Common Stock (2250) Direct

Footnotes

F1: Represents the weighted average sale price of $68.1333. The range of prices for the sale of these shares was $68.13 - $68.15, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: The Stock Appreciation Rights were granted on 4/13/2011 and 50% vested each on 4/13/2014 and 4/13/2015.

F3: The Stock Appreciation Rights were granted on 12/18/2012 and 50% vested on 4/1/2015.